Dr. Althea 0.1% Gentle Retinol Serum by Dr. Althea
Dr. Althea

0.1% Gentle Retinol Serum

Serums

26/100
High risk

Pregnancy-focused rating

Higher-risk ingredients are flagged in this formula. Discuss alternatives with your healthcare professional.

32 of 32 ingredients rated

Is it suitable during pregnancy?

MamaSkin rates the recorded formula for Dr. Althea 0.1% Gentle Retinol Serum as High risk (26/100). This is not a pregnancy-safe recommendation. Discuss alternatives with a qualified healthcare professional.

Why this rating?

The recorded formula includes 3 ingredient entries with risk flags: Retinol (High risk), Borago Officinalis Extract (Low risk), Salvia Sclarea Extract (Low risk). These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail.

32 of 32 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.

How we assess products

Ingredient breakdown

The recorded formula, with evidence behind each rating. Unmatched ingredients are marked Not assessed in grey.

Ingredient ratings and evidence

Higher-risk flags first. Open an ingredient for evidence.

Retinol

High risk

Vitamin A derivative. Systemic retinoids are known teratogens, and topical retinoids are avoided during pregnancy due to class-wide risk and limited safety margins. Avoid use during pregnancy regardless of formulation.

Sources: EMA: Updated measures for pregnancy prevention during retinoid use https://www.ema.europa.eu/en/news/updated-measures-pregnancy-prevention-during-retinoid-use; FDA: Pregnancy and Lactation Labeling Rule https://www.fda.gov/drugs/labeling-information-drug-products/questions-and-answers-pregnancy-and-lactation-labeling-rule

Borago Officinalis Extract

Low risk

Unspecified borage extract is distinct from purified seed oil. Other plant parts can contain unsaturated pyrrolizidine alkaloids associated with hepatic, genotoxic and developmental concerns after systemic exposure. Dermal exposure and composition are uncertain, so MamaSkin applies Low Risk.

Sources: LactMed https://pubmed.ncbi.nlm.nih.gov/30000849/; PA profiling https://pubmed.ncbi.nlm.nih.gov/36924638/; PA review https://pubmed.ncbi.nlm.nih.gov/30704105/.

Salvia Sclarea Extract

Low risk

Salvia sclarea extract is not automatically equivalent to clary-sage essential oil, but solvent extracts may contain the diterpene sclareol. European scientific review found the submitted sclareol safety data inadequate, while experimental uterine work demonstrates biological activity without establishing pregnancy harm from cosmetic exposure. MamaSkin applies precautionary Low Risk rather than High Risk.

Sources: SCCP Opinion on Sclareol SCCP/0986/06 https://ec.europa.eu/health/archive/ph_risk/committees/04_sccp/docs/sccp_o_056.pdf; PubMed 33066489 https://pubmed.ncbi.nlm.nih.gov/33066489/; European Commission CosIng.

Water

No known risks

Water (Aqua) is the standard purified water used as a cosmetic solvent. It has no pregnancy-specific risk in normal topical use.

Sources: https://pubchem.ncbi.nlm.nih.gov/compound/Water, https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database/cosing-glossary-ingredients_en

Glycerin

No known risks

Glycerin is a widely used humectant that supports hydration and the skin barrier, with a long safety record and no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Show all 32 ingredients

Butylene Glycol

No known risks

Solvent and humectant commonly used in leave-on products. Not associated with pregnancy-specific concerns at cosmetic exposure levels.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Dibutyl Adipate

No known risks

A diester used as an emollient, solvent and plasticizer. After reviewing additional dermal, reproductive, developmental and genotoxicity data, cosmetic safety reviewers concluded that dibutyl adipate is safe in current cosmetic use and concentration. No pregnancy-specific concern is identified for normal topical cosmetic exposure.

Sources: CIR: Amended Final Report of the Safety Assessment of Dibutyl Adipate https://cir-reports.cir-safety.org/view-attachment?id=f1624b41-8e74-ec11-8943-0022482f06a6

1,2-Hexanediol

No known risks

1,2-Hexanediol is commonly used as a solvent and preservative booster; topical exposure is low and it has no known pregnancy or breastfeeding concerns at cosmetic concentrations, though very sensitive skin may occasionally react.

Sources: CIR; EU/UK Cosmetics Regulation

Panthenol

No known risks

Panthenol (pro-vitamin B5) is used for soothing and barrier support and is generally well tolerated, with no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Glycine Soja Oil

No known risks

Plant-derived emollient oil used to soften skin and support formula texture. Reviewed cosmetic safety sources support current cosmetic use, with no pregnancy- or breastfeeding-specific topical concern identified in the material reviewed.

Sources: CIR: Safety Assessment of Soy-Derived Ingredients as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Hydrogenated Lecithin

No known risks

Hydrogenated emulsifier used to support skin barrier feel. Not associated with pregnancy-specific concerns.

Sources: Cosmetic Ingredient Review (US)

Caprylic/Capric Triglyceride

No known risks

Common emollient derived from fatty acids and glycerin. Used to soften skin and improve texture without pregnancy-specific concerns.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Polyglyceryl-3 Methylglucose Distearate

No known risks

An emulsifier built from polyglycerin, methyl glucose and stearic-acid components, used to stabilise creams and improve texture. Exact pregnancy-specific data are limited. Cosmetic safety reviewers concluded that related methyl glucose esters and polyglyceryl fatty-acid esters are safe in current cosmetic use when formulated to be non-irritating. No pregnancy-specific topical concern was identified by applying those related-group assessments to ordinary cosmetic exposure.

Sources: CIR: Safety Assessment of Methyl Glucose Polyethers and Esters https://www.cir-safety.org/supplementaldoc/safety-assessment-methyl-glucose-polyethers-and-esters-used-cosmetics; CIR: Safety Assessment of Polyglyceryl Fatty Acid Esters https://cir-safety.org/sites/default/files/PGlyFE092016FR.pdf

Sodium Polyacrylate

No known risks

Polymer used for texture and absorbency. Large-molecule ingredient with low systemic exposure.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer

No known risks

Large polymer thickener, stabilizer and texture ingredient used in gels, creams and sunscreens. Systemic exposure from topical cosmetic use is expected to be low, with no pregnancy- or breastfeeding-specific concern identified in reviewed cosmetic references.

Sources: CIR cosmetic ingredient safety references for acrylates copolymers; EU CosIng / cosmetics regulatory inventory

Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer

No known risks

A large synthetic polymer used to thicken and stabilise cosmetic emulsions. Related acrylate copolymers have low dermal absorption because of their molecular size, and cosmetic safety reviewers concluded that this polymer family is safe when formulas avoid irritation and residual monomers are appropriately controlled. Exact pregnancy-specific topical studies are limited, but no pregnancy-specific concern was identified for normal exposure to the finished polymer in a compliant cosmetic.

Sources: CIR: Amended Safety Assessment of Acrylates Copolymers as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6; CIR: Final Report on Acrylates Copolymer and Related Ingredients https://cir-reports.cir-safety.org/view-attachment/?id=c9cc1a17-8e74-ec11-8943-0022482f06a6

Betula Alba Juice

No known risks

A botanical extract, plant water or plant juice used for conditioning, soothing or antioxidant support. Direct pregnancy studies of this exact cosmetic material were not identified, but no reproductive or developmental hazard was identified for normal topical exposure. Oral herbal or medicinal use is outside this classification.

Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant plant-derived ingredient assessments; no ingredient-specific human pregnancy study of normal topical cosmetic use was identified.

Bakuchiol

No known risks

Bakuchiol is a plant-derived skincare ingredient used as a retinol alternative. Although it can show some retinol-like cosmetic effects, it is not a retinoid or vitamin A derivative. Human topical studies suggest good tolerability, and current literature does not identify a known pregnancy-specific risk signal for topical cosmetic use. Overall, it is generally considered a lower-concern alternative to retinoids in pregnancy, while recognising that direct pregnancy-specific studies remain limited.

Sources: PubMed (NLM): Chaudhuri & Bojanowski 2014 (PMID 24471735); Br J Dermatol bakuchiol vs retinol randomized trial (PMID 29947134); J Drugs Dermatol bakuchiol moisturizer trial in sensitive skin (PMID 33346506); J Drugs Dermatol systematic review of human topical bakuchiol trials (PMID 38564402); Contact Dermatitis case reports (PMIDs 30644106, 31423588); PMC review noting lack of pregnancy-specific studies (PMCID PMC10683784).

Polyisobutene

No known risks

A large, mostly insoluble polymer used as a binder, film former and texture ingredient. Cosmetic safety reviewers concluded that polyisobutene is safe in current cosmetic use; slow absorption and reproductive data on related polybutene do not indicate a pregnancy-specific concern from normal topical exposure.

Sources: CIR: Final Report on Polyisobutene and Hydrogenated Polyisobutene https://www.cir-safety.org/sites/default/files/polyene.pdf

Ethylhexylglycerin

No known risks

Preservative booster and skin-conditioning agent. Considered safe for cosmetic use with low systemic exposure when used as intended.

Sources: Scientific Committee on Consumer Safety (EU); Cosmetic Ingredient Review (US)

Allantoin

No known risks

Allantoin is a soothing skin protectant commonly used to help reduce irritation and support comfort, with no known pregnancy or breastfeeding concerns in topical cosmetic use.

Sources: CIR; EU/UK Cosmetics Regulation

Glyceryl Acrylate/Acrylic Acid Copolymer

No known risks

A high-molecular-weight polymer used to hold water and stabilise texture. Cosmetic safety reviewers concluded that glyceryl acrylate/acrylic acid copolymer is safe in current cosmetic practices. Dermal absorption of the finished polymer is expected to be limited; residual monomers should be controlled by cosmetic manufacturing standards.

Sources: CIR: Safety Assessment of Glyceryl Acrylate/Acrylic Acid Copolymer and Glyceryl Polyacrylate https://cir-reports.cir-safety.org/view-attachment/?id=c79ac89b-d78d-055f-ba88-45f4f5a039b3

Disodium EDTA

No known risks

Disodium EDTA is a chelating agent used to improve formula stability and performance; it is considered low concern in topical cosmetic use, with no known pregnancy or breastfeeding risks at typical concentrations.

Sources: CIR; EU/UK Cosmetics Regulation

Sorbitan Isostearate

No known risks

Emulsifier used to help oil and water phases remain mixed. Reviewed cosmetic safety sources support topical use in cosmetics; the main practical issue is irritation potential in some formulas rather than a pregnancy-specific concern.

Sources: CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics; EU CosIng / cosmetics regulatory inventory

Pvm/Ma Copolymer

No known risks

A high-molecular-weight film-forming copolymer used in hair, oral-care and skin products. Cosmetic safety reviewers concluded that PVM/MA copolymer is safe in current practices of use and concentration. Absorption of the intact polymer is expected to be limited.

Sources: CIR: Safety Assessment of PVM/MA Copolymer and Its Esters, IJT 30(Suppl. 2), 2011; December 2025 Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf

Sorbitan Oleate

No known risks

This sorbitan fatty-acid ester is an emulsifier that helps oil and water phases remain mixed. The Cosmetic Ingredient Review concluded that sorbitan esters are safe in current cosmetic use; occasional contact reactions remain possible in sensitive users.

Sources: CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics https://www.cir-safety.org/supplementaldoc/safety-assessment-sorbitan-esters-used-cosmetics

Caprylyl/Capryl Glucoside

No known risks

This glucose-derived nonionic surfactant or emulsifier is used in cleansers and emulsions. The Cosmetic Ingredient Review concluded that alkyl glucosides are safe in current cosmetic use when formulated to be non-irritating; sensitive skin can still react to surfactants.

Sources: CIR: Safety Assessment of Decyl Glucoside and Other Alkyl Glucosides as Used in Cosmetics https://cir-reports.cir-safety.org/view-attachment/?id=9810a771-8e74-ec11-8943-0022482f06a6

Hyacinthus Orientalis Extract

No known risks

hyacinthus orientalis extract is a botanical-derived cosmetic conditioning ingredient. The reviewed identity is not an essential oil or an oral herbal preparation. Available cosmetic evidence and expected topical exposure did not identify a pregnancy-specific contraindication, although botanical irritation or allergy remains possible.

Sources: CIR ingredient-specific and botanical-family safety assessments; CIR Quick Reference Table https://cir-safety.org/sites/default/files/QRT-Update-Dec2025.pdf; European Commission CosIng

Chamomilla Recutita Flower Extract

No known risks

A German chamomile flower extract used for skin conditioning and soothing. Cosmetic safety reviewers concluded that Chamomilla recutita flower-derived ingredients are safe in current cosmetic use when formulated to be non-sensitizing. Chamomile can cause contact allergy in susceptible people, particularly those sensitive to plants in the Asteraceae family, but no pregnancy-specific concern is identified for normal topical cosmetic exposure.

Sources: CIR: Safety Assessment of Chamomilla Recutita-Derived Ingredients as Used in Cosmetics https://cir-safety.org/supplementaldoc/safety-assessment-chamomilla-recutita-derived-ingredients-used-cosmetics-0

Centaurea Cyanus Flower Extract

No known risks

A cornflower extract used for soothing and skin conditioning. No pregnancy- or breastfeeding-specific hazard was identified for normal topical cosmetic exposure. Direct ingredient-specific pregnancy studies were not identified, so this assessment does not extend to oral supplements or medicinal use.

Sources: European Commission CosIng ingredient inventory; Cosmetic Ingredient Review botanical safety-assessment framework and relevant ingredient-family assessments. No ingredient-specific human pregnancy study of normal topical cosmetic use was identified.

Lavandula Angustifolia Flower Extract

No known risks

A plant-part extract used for skin conditioning, soothing, fragrance or antioxidant support. No pregnancy-specific systemic signal was identified for normal topical cosmetic exposure. This assessment does not extend to essential oils, oral herbal products or medicinal doses, and botanical sensitivity remains possible.

Sources: European Commission CosIng ingredient inventory; CIR botanical safety framework and relevant plant-derived ingredient assessments; peer-reviewed cosmetic-use literature.

Tocopherol

No known risks

Vitamin E antioxidant used to protect oils and support the skin barrier. Not associated with pregnancy-specific concerns at cosmetic exposure.

Sources: Cosmetic Ingredient Review (US); Scientific Committee on Consumer Safety (EU)

Full recorded ingredient list

Water, Glycerin, Butylene Glycol, Dibutyl Adipate, 1,2-Hexanediol, Panthenol, Glycine Soja Oil, Hydrogenated Lecithin, Caprylic/Capric Triglyceride, Polyglyceryl-3 Methylglucose Distearate, Sodium Polyacrylate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Betula Alba Juice, Retinol, Bakuchiol, Polyisobutene, Ethylhexylglycerin, Allantoin, Glyceryl Acrylate/Acrylic Acid Copolymer, Disodium EDTA, Sorbitan Isostearate, Pvm/Ma Copolymer, Sorbitan Oleate, Caprylyl/Capryl Glucoside, Hyacinthus Orientalis Extract, Borago Officinalis Extract, Chamomilla Recutita Flower Extract, Centaurea Cyanus Flower Extract, Salvia Sclarea Extract, Lavandula Angustifolia Flower Extract, Tocopherol

Ingredient ratings refreshed 29 October 2026. Formulas vary by market and can change. Always compare with your packaging.

Questions about this assessment

Why does Dr. Althea 0.1% Gentle Retinol Serum have a High risk rating?

The recorded formula includes 3 ingredient entries with risk flags: Retinol (High risk), Borago Officinalis Extract (Low risk), Salvia Sclarea Extract (Low risk). These are ingredient-level flags; they do not replace the stored product assessment or account for every formulation detail. The product score is a stored assessment, not a clinical safety guarantee.

Does a barrier-care product name establish pregnancy suitability?

No. This recorded formula contains Panthenol or Madecassoside, but a barrier-care claim does not establish the assessment of all its other ingredients. Read the individual ingredient evidence and any manual-review explanation, and compare the recorded list with your packaging.

Has every ingredient in Dr. Althea 0.1% Gentle Retinol Serum been assessed?

32 of 32 ingredient entries on this page have a recorded score, evidence summary and source text. That describes documentation coverage, not proof that the finished formula has been clinically tested during pregnancy.

Does this assessment apply to my Dr. Althea 0.1% Gentle Retinol Serum?

Only if the ingredient list on your packaging matches the recorded formula shown here. Formulas can differ by market and change over time. Compare the full list, not just the product name; report a mismatch if it differs.

Does this pregnancy assessment also establish breastfeeding suitability?

No. This page presents a pregnancy-focused product assessment. Do not infer a breastfeeding conclusion from its score or label; breastfeeding requires a separate assessment of the formula and how it is used.